SalA treatment effectively attenuated hepatic oxidative stress in HFD-fed rats; thus, we investigated whether SalA confers protection against NAFLD by regulating TXNIP. This evidence concerns the gene TXNIP and metabolic dysfunction-associated steatotic liver disease.